Related Experiment Videos
Polymorphisms in the genes encoding platelet-derived growth factor A and alpha receptor.
S M Herrmann1, S Ricard, V Nicaud
1Institut National de la Santé et de la Recherche Médicale (Inserm) SC7/U525, Génétique épidémiologique et Moléculaire des pathologies cardiovasculaires, Paris, France. herrmann@medizin.fu-berlin.de
Journal of Molecular Medicine (Berlin, Germany)
|August 23, 2000
Summary
Genetic variations in Platelet-Derived Growth Factor A (PDGF-A) and PDGF Receptor Alpha (PDGF-Ralpha) genes were not associated with myocardial infarction risk in European populations. This study found no link between these specific gene polymorphisms and coronary heart disease development.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Molecular Biology
Background:
- Platelet-Derived Growth Factors (PDGFs) are implicated in atherosclerosis development, influencing vascular smooth muscle cells and macrophages.
- Distinct PDGF (AA, AB, BB) forms and their receptors (PDGF-Ralpha, PDGF-Rbeta) exhibit varied activities.
- Investigating genetic variants in PDGF-A and PDGF-Ralpha is crucial for understanding coronary heart disease (CHD) etiology.
Purpose of the Study:
- To screen for polymorphisms in human PDGF-A and PDGF-Ralpha genes.
- To determine if identified gene variants contribute to the risk of myocardial infarction (MI).
- To analyze the association of these polymorphisms with cardiovascular risk factors.
Main Methods:
- Polymerase chain reaction/single-strand conformation polymorphism (PCR/SSCP) analysis was used to identify polymorphisms.
- Genotyping of PDGF-A and PDGF-Ralpha polymorphisms was performed in 600 MI patients and 717 controls (ECTIM Study).
- Allele-specific oligonucleotides were employed for genotyping various identified polymorphisms.
Main Results:
- No significant differences in genotype or allele frequencies of PDGF-A and PDGF-Ralpha polymorphisms were observed between MI patients and controls.
- The identified PDGF-A and PDGF-Ralpha polymorphisms showed heterozygosity of 0.69 and 0.40, respectively.
- None of the investigated polymorphisms were associated with blood pressure, coronary artery stenosis, or biochemical parameters.
Conclusions:
- The studied polymorphisms in the PDGF-A and PDGF-Ralpha genes do not appear to be risk factors for myocardial infarction in the examined European populations.
- Further research may be needed to explore other genetic factors influencing coronary heart disease.
- The findings suggest that variations in PDGF-A and PDGF-Ralpha are unlikely to be major contributors to CHD susceptibility.